Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9341021 | Urologic Oncology: Seminars and Original Investigations | 2005 | 5 Pages |
Abstract
In the modern era, DNA ploidy is not an independent predictor of either overall survival or recurrence-free survival in patients with nonmetastatic RCC. The most important predictor of recurrence-free survival is tumor differentiation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Peter E. M.D., Joseph A. M.D., Matthew R. M.D., Ralph D. M.D., M. Craig M.D.,